Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination

Akiko Morimoto, Yoshito Terai(Osaka Medical and Pharmaceutical University), Yutaka Ueda(Osaka Gakuin University), Junko Saito, Masami Fujita(The University of Osaka), Masayuki Sekine(Niigata University Medical and Dental Hospital), Yorihiko Horikoshi, Hiromi Murata(Kansai Medical University), Tomomi Egawa‐Takata(The University of Osaka), Masaki Mandai(Kyoto University), Tadashi Kimura(Osaka University), Takayuki Enomoto(Itami City Hospital), Tomotaka Sobue(The University of Osaka), Nobumichi Nishikawa(Niigata University Medical and Dental Hospital), Asami Yagi(The University of Osaka), Hidekatsu Nakai(Kindai University), Tomoyuki Ichimura(Osaka City University), Toshiyuki Sumi(Osaka City University), Hideharu Kanzaki(ProQuest (United States)), Kiyoshi Yoshino(University of Occupational and Environmental Health Japan), Masahide Ohmichi(Osaka University of Pharmaceutical Sciences)
International Journal of Clinical Oncology
July 8, 2014
Cited by 61


Related Papers